Therefore, the upregulation of AXL induced by doxorubicin treatment or present in doxorubicin‐resistant cancer cells (Fig. 2) and YAP‐dependent AXL expression (Fig. 3) suggests that YAP/TAZ activation may occur by doxorubicin treatment alone. Here, YAP1 is linked to cancer.